Skip to main content
Ir a la página de inicio de la Comisión Europea (se abrirá en una nueva ventana)
español es
CORDIS - Resultados de investigaciones de la UE
CORDIS

Non-invasive Glucose Health Technology

Objetivo

"Diabetes affects over 589 million people and remains a leading cause of severe complications including cardiovascular disease and blindness. Effective management relies on frequent glucose monitoring, yet current methods impose significant barriers.
Self monitoring with finger pricks is painful, inconvenient, and stigmatizing, leading to poor compliance. Continuous glucose monitors (CGMs) have improved insights but remain invasive, requiring skin penetration, adhesives, and costly consumables. They are also prone to malfunctions and cover only 2–4% of patients due to cost, discomfort, and technical complexity.
Both approaches generate substantial biohazard waste, further limiting sustainability.
DiaMonTech’s D-Pocket introduces the first truly non-invasive glucose monitoring device. Based on proprietary mid-infrared photothermal detection, the handheld sensor allows users to measure glucose levels painlessly, simply by placing a finger or wrist on the device. The D-Pocket addresses the most cited barriers to regular monitoring: pain, anxiety, infection risk, and waste generation.
Non-invasive monitoring increases daily measurement frequency and this translates into significant reductions in microvascular complications and improved long-term outcomes, as demonstrated in landmark diabetes trials.
The D-Pocket is achieving better health outcomes for its primary target group - people with type 2 diabetes who currently rely on finger pricks. The D-Pocket empowers millions to manage their disease more effectively, and contributes to healthier, longer lives.
DiaMonTech AG is a medical technology company with the mission ""to improve the quality of life for everyone by unlocking health data"". It has received approximately EUR 25m in funding to date plus another ~EUR 10m during the EIC application phase and is currently seeking an additional EUR 2.5m grant and EUR 7.5m equity from the EIC to finalize development, achieve certification, and begin marketing the device.
"

Ámbito científico (EuroSciVoc)

Este proyecto aún no se ha clasificado con EuroSciVoc.
Sugiera los ámbitos científicos que considere más relevantes y ayúdenos a mejorar nuestro servicio de clasificación.

Palabras clave

Programa(s)

Tema(s)

Régimen de financiación

HORIZON-EIC-ACC - HORIZON EIC Accelerator

Ver todos los proyectos financiados en el marco de este régimen de financiación

Convocatoria de propuestas

(se abrirá en una nueva ventana) HORIZON-EIC-2026-ACCELERATOR-02

Ver todos los proyectos financiados en el marco de esta convocatoria

Coordinador

DiaMonTech AG
Aportación neta de la UEn
€ 2 499 999,00
Dirección
Boxhagener Strasse 82 A
10245 Berlin
Alemania
Pyme
Sí
Región
Berlin Berlin Berlin
Tipo de actividad
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Enlaces
Coste total
Sin datos